Header

UZH-Logo

Maintenance Infos

Highlights and recent developments in airway diseases in EAACI journals (2017)


Bousquet, J; Akdis, C A; Grattan, C; Eigenmann, P A; Hoffmann-Sommergruber, K; Hellings, P W; Agache, I (2018). Highlights and recent developments in airway diseases in EAACI journals (2017). Clinical and Translational Allergy, 8(1):49.

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. There was substantial progress in 2017 in the identification of basic mechanisms of allergic and respiratory disease and the translation of these mechanisms into clinics. Better understanding of molecular and cellular mechanisms, efforts for the development of biomarkers for disease prediction, novel prevention and intervention studies, elucidation of mechanisms of multimorbidies, entrance of new drugs in the clinics as well as recently completed phase three clinical studies and publication of a large number of allergen immunotherapy studies and metaanalyses have been the highlights of the last year.

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. There was substantial progress in 2017 in the identification of basic mechanisms of allergic and respiratory disease and the translation of these mechanisms into clinics. Better understanding of molecular and cellular mechanisms, efforts for the development of biomarkers for disease prediction, novel prevention and intervention studies, elucidation of mechanisms of multimorbidies, entrance of new drugs in the clinics as well as recently completed phase three clinical studies and publication of a large number of allergen immunotherapy studies and metaanalyses have been the highlights of the last year.

Statistics

Citations

Altmetrics

Downloads

9 downloads since deposited on 13 Feb 2019
9 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Swiss Institute of Allergy and Asthma Research
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:1 December 2018
Deposited On:13 Feb 2019 12:49
Last Modified:13 Feb 2019 12:51
Publisher:BioMed Central
ISSN:2045-7022
OA Status:Gold
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1186/s13601-018-0238-3
PubMed ID:30498567

Download

Download PDF  'Highlights and recent developments in airway diseases in EAACI journals (2017)'.
Preview
Content: Published Version
Filetype: PDF
Size: 766kB
View at publisher
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)